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The transglutaminase I (TGase I) gene encodes an en-
zyme that catalyzes the cross-linking of structural pro-
teins involved in the formation of the cornified envelope
during squamous cell differentiation. To identify DNA
elements important for the transcriptional control of
the TGase I gene, we analyzed the ability of a 2.9-kilo-
base pair (kb) upstream regulatory region to control the
expression of a reporter gene in vivo and in vitro. Trans-
genic mice bearing the pTG(22.9kb)CAT construct ex-
hibited the same pattern of tissue-specific expression of
CAT as reported for TGase I. Deletion analysis in tran-
siently transfected rabbit tracheal epithelial cells indi-
cated that two sequences from bp 2490 to 2470 and from
254 to 237 are involved in the activation of TGase I
transcription. Point mutation analysis and mobility
shift assays showed that the sequence located between
254 and 237 is a functional Sp1-like transcription ele-
ment. Sp1 and Sp3, but not Sp2, are part of nuclear
protein complexes from differentiated RbTE cells bind-
ing to this site. The element TGATGTCA between bp
2490 and 2470 is contained in a larger 22-bp palindrome
and resembles the consensus cAMP response element-
binding protein (CREB)/AP-1 element recognized by di-
meric complexes of members of the CREB, ATF, Fos, and
Jun families. Mutations in this sequence greatly re-
duced promoter activity. Supershift analysis identified
CREB1, JunB, c-Fos, Fra-1, and c-Jun in protein com-
plexes isolated from differentiated rabbit tracheal epi-
thelial cells binding to this site. Our study shows that
the Sp1- and CREB/AP-1-like sites act in concert to stim-
ulate transcription of the TGase I gene. The 2.9-kb pro-
moter region could guide expression of specific genes in
the granular layer of the epidermis and could be useful
in gene therapy.
Transglutaminases (TGases)1 (EC 2.3.2.13) constitute a fam-
ily of Ca21-dependent enzymes that covalently cross-link pro-
teins by catalyzing the formation of isopeptide bonds between
the g-amide group of glutamine and the e-amino group of lysine
(1–5). TGases have functions in a variety of biological pro-
cesses, such as differentiation, apoptosis, and blood clotting
(4–9), and are implicated in a number of diseases (4, 10–12).
Factor XIII catalyzes the cross-linking of a number of proteins
in plasma and plays an important role in fibrinogenesis (1, 2, 4,
5). Tissue TGase (TGase II) has been implicated in the activa-
tion of certain cytokines (13, 14) and cross-linking of specific
components of the extracellular matrix (4). This TGase has also
been reported to have GTPase activity and as such may have a
role in signal transduction (15). In addition, evidence has been
provided indicating that TGase II may catalyze cross-linking of
intracellular proteins during apoptosis (8, 16). TGase I and III
are involved in the formation of the cross-linked envelope dur-
ing squamous cell differentiation (5–7,17–19).
Squamous differentiation is a terminal pathway of differen-
tiation that occurs as a multistep process (21–23). In epidermal
keratinocytes this differentiation represents a normal process,
whereas in tracheobronchial epithelial cells, it is an aberrant
pathway of differentiation that occurs under conditions of se-
vere vitamin A deficiency or after injury (20–22). Early during
differentiation, cells become committed to irreversible growth
arrest that is accompanied by alterations in the expression of
several growth-regulatory genes (6, 23–25). In subsequent
stages in the differentiation process, cells begin to express a
variety of squamous-specific genes (20–22). In tracheobron-
chial epithelial cells, squamous differentiation is associated
with induction of keratin 13 (26, 27), relaxin (28), cholesterol
sulfotransferase (29), epithelial membrane protein 1 (30), and
several proteins involved in the formation of the cross-linked
envelope (31–38).
The formation of the cross-linked envelope is a characteristic
event in the final stages of squamous differentiation. The en-
velope consists of a layer of cross-linked protein deposited just
beneath the plasma membrane (5–7, 18). It contributes to the
cohesiveness and rigidity of the cornified layer and provides a
vital barrier function. The envelope is formed by the cross-
linking of many precursor proteins, including involucrin (38),
cornifins/small proline-rich proteins (SPRRs) (32, 35, 36), and
loricrin (37) catalyzed by TGase I and III (5–7, 17–19). TGase I
is synthesized as a soluble enzyme in the cytosol and becomes
associated with the cell membrane after acylation by palmitic
and myristic acid at a cluster of five cysteines at its amino
terminus (39, 40). The TGase I gene has been cloned from
various species (33, 41, 42). The human TGase I gene, which
spans 14.3 kb and contains 15 exons, has been mapped to
chromosome 14q11 (TGM1 locus) (43–45). The importance of
this enzyme in the morphogenesis and function of the skin was
recently corroborated by studies implicating mutations in the
TGase I gene that result in a lack of TGase I activity in the
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autosomal recessive skin disorder lamellar ichthyosis (11, 12).
Recent studies demonstrated that TGase I-null mice exhibit
severe deficiencies in several skin functions, including impair-
ments in cell envelope assembly and barrier function (46).
Analysis of the TGase I promoter may provide insight not
only into the molecular mechanisms controlling this gene in
squamous epithelia and squamous metaplasia but also into the
molecular pathogenesis of lamellar ichthyosis and lead to new
methods of treatment, including drug and gene therapy. In this
study, we analyzed the ability of a 2.9-kb promoter regulatory
region of the TGase I gene to control the expression of a chlor-
amphenicol acetyltransferase (CAT) reporter gene in vivo and
in vitro. We show that this region directs expression of the
transgene to the suprabasal layers, comprising the late spinous
and granular layers, of several squamous tissues. This pattern
of expression correlates well with that reported for TGase I (47,
48). Deletion analysis identified two DNA elements in the
2.9-kb regulatory region containing an Sp1- and a CREB/AP-
1-like site that are involved in the transcriptional regulation of
TGase I.
EXPERIMENTAL PROCEDURES
Cell Culture—Rabbit tracheobronchial epithelial (RbTE) cells were
cultured in Ham’s F-12 medium supplemented with 10 ng/ml epidermal
growth factor, 5 mg/ml transferrin, and insulin as described previously
(49). Normal human epidermal keratinocytes (NHEK) were purchased
from Clonetics (San Diego, CA) and cultured in KGM medium (Clonet-
ics). Rabbit tracheal fibroblasts were grown in Ham’s F-12/RPMI 1640
(1:1) supplemented with 10% fetal bovine serum.
Plasmids and Reporter Constructs—The plasmid pTG(22.9kb)-LUC
containing the luciferase reporter gene under the control of the 22.9 kb
promoter flanking region of the TGase I gene has been previously
described (34). The deletion mutants pTG(21.5kb)-LUC and
pTG(2350)-LUC were constructed using the SmaI and ApaI restriction
sites (Fig. 1A). The minimal promoter construct pTG(237)-LUC and
pTG(254)-LUC were made by cloning the respective PCR products into
the promoterless luciferase vector pGL2-Basic (Promega). Deletion mu-
tants in region 2750 to 2350 bp were constructed by PCR-directed
cloning into the construct pTG(237)-LUC (Fig. 2A). All PCR reactions
were conducted with proofreading Vent DNA polymerase (New England
Biolabs), and the original 2.9-kb construct was used as template. All
primers contained a six-base 59-leader sequence followed by a six-base
restriction site (KpnI, MluI, or XhoI) and a 20-base promoter sequence.
Point mutation constructs were made by direct cloning of chemically
synthesized oligonucleotides upstream of pTG(237)-LUC. The se-
quences of the PCR products were checked for accuracy using the
dideoxynucleotide chain termination method and the Sequenase Quick-
denature plasmid sequencing kit (Amersham Pharmacia Biotech).
Search for Transcription Factor Binding Sites—Promoter flanking
regions were analyzed for the presence of potential transcription factor
binding sites using the TFSEARCH Program.2
Transfections and Reporter Gene Assays—Plasmid DNA used in
transfections were isolated and purified with a Wizard Miniprep kit
(Promega). RbTE cells were grown to confluence in six-well dishes, and
transfections were carried out in triplicate using lipofectamine (Life
Technologies, Inc.) according to the manufacturer’s protocol. Cells were
incubated in 1.0 ml of Ham’s F-12 medium without growth factors and
antibiotics in the presence of 1.5 mg of total DNA and 5 ml of lipo-
fectamine. Cotransfection with b-actin-CAT reporter plasmid was car-
ried out to correct for differences in transfection efficiency. After a 5-h
incubation, medium was replaced with complete F-12 or KGM medium.
Cells were collected 48 h after transfection and assayed for reporter
activity. Whole cell extracts were prepared with the lysis buffer in-
cluded in the CAT ELISA kit (Boehringer Mannheim) according to the
manufacturer’s protocol and used in CAT and luciferase assays. Lucif-
erase assays were performed with the Luciferase Assay Kit from Pro-
mega. The relative luciferase activity was normalized for CAT reporter
activity.
Electrophoretic Mobility Shift Assays (EMSAs)—Nuclei were isolated
from differentiated rabbit tracheobronchial epithelial cells, and nuclear
extracts were prepared by the method of Dignam et al. (50) with slight
modifications. Briefly, cells were washed twice in ice-cold PBS, collected
into microtubes, and centrifuged for 10 s in a microcentrifuge. The cell
pellet was then resuspended in 1 ml of ice-cold, low salt buffer (10 mM
HEPES, pH 7.9, 1 mM EDTA, 0.5 mM EGTA, 10 mM KCl, 1 mM phen-
ylmethylsulfonyl fluoride, 0.5 mM dithiothreitol, 5 mg/ml leupeptin and
aprotinin, 0.1 mM sodium vanadate). After incubation on ice for 20 min,
Nonidet P-40 was added to a final concentration of 0.5%. The cell
suspension was vigorously vortexed for 20 s followed by centrifugation
for 30 s in a microcentrifuge to collect the nuclei. The nuclei were
resuspended in 10 volumes of high salt buffer (10 mM HEPES, pH 7.9,
1 mM EDTA, 0.42 M NaCl, 10% glycerol, and protease inhibitors) and
incubated on ice for 20 min followed by a 10-min centrifugation in a
microcentrifuge at 4 °C. Nuclear extracts were collected and stored in
aliquots at 270 °C.
The Sp1 consensus oligonucleotide (CTCCGCCCCGCCCGATC-
GAAT), the AP-1 consensus (CGCTTGATGAGTCAGCCGGAA), the
2 This program is available on the World Wide Web at
http://pdap1.trc.rwcp.or.jp/research/db/TFSEARCH.html.
FIG. 1. A, Schematic view of the
pTG(22.9)-CAT construct used in the
TGase promoter analysis in transgenic
mice. The TATA-box-like sequence
CATAA is indicated. B, relative CAT ac-
tivity in various tissues from transgenic
mice expressing pTG(22.9)-CAT. The rel-
ative CAT activity in protein extracts
from various tissues was determined by
enzyme-linked immunosorbent assay.
Tissues from normal (1) and two trans-
genic mice of two different lines (2 and 3)
were analyzed. Only skin, tongue, and
esophagus, which normally express
TGase I, contained CAT protein. The as-
say was done in triplicate, and the S.D.
was less then 10%. Sk, skin; Es, esopha-
gus; To, tongue; Lu, lung; Ki, kidney; Li,
liver; Te, testis; Mu, muscle; Br, brain.
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CREB consensus (GTACTGGCTGCTGACGTCACCAGCCA), and
other oligonucleotides were synthesized using a model 392 DNA syn-
thesizer (Applied Biosystems). Oligonucleotides for EMSA were end-
labeled with [g-32P]ATP by T4 polynucleotide kinase (Promega) and
purified with NAP-5 columns (Amersham Pharmacia Biotech). Approx-
imately 0.1 ng (50,000 cpm) of the oligonucleotide probe and 0.5 mg of
nuclear extract were used in the binding reaction in buffer containing
20 mM HEPES, pH 7.9, 50 mM NaCl, 1 mM EDTA, 1 mM phenylmeth-
ylsulfonyl fluoride, 10% glycerol. To prevent nonspecific binding, 1 mg of
poly(dI-dC) and 0.2 mg of salmon sperm DNA were included in the
reaction. The binding reactions were carried out at room temperature
for 25 min in the presence or absence of a 10- or 100-fold molar excess
of oligonucleotide competitors. For supershift analysis, various antibod-
ies were included in the incubation mixture. DNA-protein complexes
were separated on 5% nondenaturing polyacrylamide gel electrophore-
sis at room temperature in 0.53 TBE. Antibodies against Sp1, Sp2, Sp3,
c-Jun, Ser63-phosphorylated c-Jun, JunB, JunD, Fra-1, Fra-2, c-Fos,
CREB1, CREB2, ATF-2, and ATF-4 were obtained from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA).
Footprint Analysis—A TGase I promoter fragment from 2750 to
2350 bp was generated by PCR with proofreading Vent DNA polymer-
ase (NE Biolabs). One of the primers used for PCR was labeled with T4
polynucleotide kinase (Promega). The binding mixture contained 20 mM
HEPES (pH 8.0), 10% glycerol, 50 mM NaCl, 10 mM MgCl2, 10–20 mg of
nuclear extract, 1 ng of labeled DNA, and 1 mg of poly(dI-dC). The
binding reaction was carried out for 25 min at room temperature and
then treated with different concentrations of DNase I. After 1 min of
incubation with DNase I, 1 volume of stop buffer (50 mM Tris-HCl pH
8.0, 10 mM EDTA, and 1% SDS) was added. DNA was purified by phenol
extraction and concentrated with Microcon-30 (Amicon). DNA frag-
ments were separated on a 6% sequencing gel.
Generation and Identification of Transgenic Mice—The construction
of the pTG-(22.9)CAT reporter was carried out by cloning the 2.9-kb
promoter fragment (KpnI/NheI restriction fragment) from
pTG(22.9)LUC into the XbaI site of the promoterless pCAT reporter
plasmid (Promega). Compatible end ligation of the NheI site into the
XbaI site was followed by incubation with T4 DNA polymerase (Amer-
sham Pharmacia Biotech). The resulting blunt ended XbaI and KpnI
sites were then autoligated. Orientation of the clones was confirmed by
sequencing. This plasmid was linearized, and a 4.5-kb HindIII/BamHI
DNA fragment containing the 22873 to 189 bp regulatory region of
TGase I gene and the CAT reporter excised. The fragment was purified
and microinjected into the pronuclei of one-cell mouse embryos obtained
from C57BL/6J females mated with SJL F2 males. The embryos were
then transferred to the oviduct of pseudopregnant females, and normal
gestation was allowed. Positive founder transgenic mice carrying the
construct were identified by PCR analysis of genomic DNA isolated
from tail biopsies. A rabbit TGase I promoter-specific primer, 59-TCG-
GCCCCGCCCTCCCCA, and a CAT-specific primer, 59-AACGGTGG-
TATATCCAGTGA, were used for the analysis. Tissues for CAT assay,
RNA isolation, and in situ hybridization were taken from 3- or 12-
month-old mice.
In Situ Hybridization—Transgenic mice were sacrificed, and tissues
isolated and fixed for 3 h with 4% paraformaldehyde in phosphate-
buffered saline, pH 7.4. After rinsing in phosphate-buffered saline,
tissues were dehydrated in a graded ethanol series, permeated with
xylene, and embedded in paraplast. In situ hybridization was per-
formed as described (51) with the following minor modification. Serial
sections (5 mm) were mounted on Silane-prep™ slides (Sigma), depar-
affinized, acetylated, and pretreated with 23 sodium citrate (SCC), 50%
formamide, 10 mM dithiothreitol at 50 °C. Radiolabeled sense and an-
tisense CAT probes were generated with either T3 or T7 RNA polym-
erase and 35S-labeled UTP and CTP (Amersham Pharmacia Biotech;
1000 Ci/mmol), as described (51). Probes were subjected to limited
alkaline hydrolysis to reduce the size of the transcripts to about 150
bases. After hybridization at 50 °C for 16 h, the sections were washed
and treated with RNase. The slides were dipped in NTB-2 emulsion
(Eastman Kodak Co.) diluted 1:1.5 and exposed for 14 days at 4 °C.
Slides were developed and counterstained with hematoxylin.
RESULTS
A 2.9-kb TGase I Promoter Region Is Sufficient for Tissue-
and Differentiation-specific Expression—The cloning and se-
quence of the 2.9-kb 59-flanking region of the rabbit TGase I
gene has been reported previously (26). We also mapped the
transcription start site and showed that this promoter region
was able to induce transactivation of the luciferase reporter
gene during differentiation of cultured RbTE cells (26). To
determine whether this region is able to control the expression
of TGase I in vivo in a cell type- and differentiation-specific
manner, we constructed an expression vector in which the CAT
reporter is under the control of the 2.9-kb 59-flanking region of
the rabbit TGase I gene and introduced this plasmid into the
mouse germ line. The presence of this transgene was corrobo-
rated by PCR. Two independent founders, which contained and
expressed the integrated transgene, were selected for subse-
quent analysis. Protein extracts prepared from various tissues
of control and transgenic mice were analyzed for CAT protein
concentration. As expected, no CAT protein was detectable in
any of the tissues isolated from control mice (Fig. 1B). In the
transgenic mice, CAT protein was only detected in crude pro-
tein extracts from tissues that normally express TGase I, in-
cluding skin, tongue, and esophagus. The highest CAT levels
were found in extracts from tongue and esophagus; lower levels
were found in skin. This pattern of CAT expression is consist-
ent with the known expression levels of TGase I in these tissues
(34). These results demonstrate that this 2.9-kb 59-flanking
region of the TGase I gene contains regulatory elements that
are sufficient to control the transcription of this gene in a
tissue-specific manner.
During squamous differentiation, cells transit from the basal
into the suprabasal layers of the epithelium and begin to ex-
press a variety of differentiation-specific genes. Initiation of
TGase I expression occurs within the late spinous and granular
cell layers of the squamous epithelium. To localize the expres-
sion of the transgene in squamous tissues, we performed in situ
hybridization using sense and antisense riboprobes to the CAT
mRNA. A specific hybridization signal was observed in the
suprabasal layers, in particular in the late spinous and gran-
ular layers of the squamous epithelium of the tongue from
transgenic mice, as shown in Fig. 2, A and B. The hybridization
signal in the basal layer was at background levels. A low
background hybridization signal was observed in squamous
epithelia of control mice with no significant differences be-
tween the different layers (Fig. 2, C and D). These results
indicate that the 2.9-kb region contains DNA elements that are
able to regulate transcription of CAT at a specific stage during
FIG. 2. Localization of CAT reporter mRNA in the stratified,
squamous-differentiated epithelium of the tongue from trans-
genic mice containing pTG(22.9)-CAT. Sections prepared from the
tongue of transgenic (A and B) and control mice (C and D) were ana-
lyzed by in situ hybridization using radiolabeled antisense CAT probe to
detect expression of CAT mRNA. A and C, bright field; B and D, dark
field exposures. The dotted line indicates the position of the basement
membrane.
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differentiation that is similar to the pattern of endogenous
TGase I expression (47).
Deletion Analysis of the TGase I Promoter—In an effort to
locate regulatory sequences important in the transcriptional
control of the TGase I gene, a series of deletion constructs were
made using several unique restriction sites within the 59-flank-
ing region or fragments generated by PCR (Fig. 3A). Transcrip-
tional activity of these pGL2-LUC constructs was analyzed by
transient transfection into primary rabbit tracheobronchial
cells cultured under differentiation-inducing conditions. Com-
pared with the activity induced by the minimal promoter (bp
237 to 160), the full-length 2.9-kb region was able to increase
luciferase activity by about 30–50-fold, depending on the ex-
periment. Deletions up to bp 2750 had only a small effect (10%
reduction) on luciferase activity, indicating that the region
between bp 22874 and 2750 does not contribute significantly
to differentiation-specific activation when transfected into
squamous-differentiated RbTE cells (Fig. 3). In contrast, dele-
tion of the region spanning bp 2750 to 2348 resulted in a 70%
decrease in luciferase activity. Further deletions of the region
up to bp 254 had only minor effects; however, deletion of the
region between bp 254 and 237 caused an additional 90%
reduction in promoter activity (Fig. 3B). As demonstrated in
Fig. 3C, the minimal TGase I promoter (pTG(237/160)LUC)
containing the TATA box-like sequence CATAA still exhibited
transactivating activity compared with the promoterless pGL2-
LUC. Deletion of this sequence (pTG(0/160bp)LUC) or the
region downstream of CATAA (pTG(237/0)LUC) completely
abolished the ability to activate transcription (Fig. 3C).
Analysis of the promoter activity of TGase I deletion con-
structs in differentiated NHEK showed that the relative tran-
scriptional activation of the reporter gene by the various pro-
FIG. 3. Analysis of the promoter activity of the 5*-regulatory region of the rabbit TGase I gene. A series of 59 deletion mutants were
made to the pTG(22.9)-LUC reporter construct and analyzed by transient transfection into differentiating RbTE cells. The constructs are named
by the size of the regulatory region. A, the relative luciferase activity for each construct was calculated and plotted. B, -fold increase in relative
luciferase activity is shown on the right in A. C, effect of deletions within the minimal promoter region (237/160) on promoter activity. The 0/160
construct contains the region downstream from the TATA-box-like sequence CATTAA, while the 237/0 construct contains the upstream region
including the TATA box.
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moter regions was very similar to that observed in RbTE cells
(Fig. 4). These results suggest that regulation of TGase I ex-
pression during squamous differentiation of tracheal bronchial
epithelial cells and epidermal keratinocytes appears to occur
largely through the same upstream-regulatory regions. How-
ever, deletion of the 22.9 kb to 2750 bp region caused a
consistently greater reduction (45%) in promoter activity in
NHEK than RbTE cells, indicating species- or cell type-specific
differences in the promoter activity of DNA elements in this
region. In contrast to RbTE and NHEK, rabbit tracheal fibro-
blasts transfected with several deletion constructs showed very
low levels of luciferase activity, and no significant difference in
promoter activity was observed between the various regions
(Fig. 4). This finding supports the conclusion that this up-
stream-regulatory region of the TGase I promoter is important
for squamous-specific regulation of TGase I in keratinocytes
and is in agreement with previous findings (34, 52–54).
The Proximal TGase I Promoter Contains a Functional Sp1
Element—The proximal region was analyzed with TFSearch
for the presence of potential transcriptional factor binding
sites. This computer search indicated that the 254/237 region
responsible for 5–10-fold transactivation of the basal TGase I
promoter contains an Sp1 consensus sequence at 247 to 240
(Fig. 5A). A two-base mutation in this Sp1 element reduced
transcriptional activity of the 254/160 fragment to that of the
minimal promoter (237/160), indicating that the increase in
transcriptional activation is related to this sequence (Fig. 5B).
Gel shift assays, using a 32P-labeled oligonucleotide TG-Sp1
corresponding to the 254/237 region and nuclear protein ex-
tracts from squamous differentiated RbTE cells, revealed the
formation of several specific DNA-protein complexes. Unla-
beled TG-Sp1 was able to compete for these complexes, while
the mutated oligonucleotide TG-mtSp1 competed much less
efficiently (Fig. 5C). A commercially available Sp1 consensus
oligonucleotide (Sp1cons.) also competed well for binding. An
antibody against Sp1 protein caused a supershift of the upper
band, indicating that Sp1 is a major part of this protein com-
plex (Fig. 5D). The second and third faster migrating bands
were supershifted by antibodies against Sp3. Antibodies
against Sp2 or Egr-1 (not shown), a transcription factor that
binds the consensus sequence GCGGGGGCG, failed to interact
with any of the protein complexes binding TG-Sp1.
Deletion Analysis of 2750/2350 Region of the TGase I Pro-
moter—To identify elements in the 2750/2350 region that are
involved in the regulation of the TGase I gene, a series of
overlapping deletion mutants was constructed by inserting var-
ious segments of this regulatory region into pTG(-37)-LUC
(Fig. 6A). Transient transfection analysis showed that the re-
gion most important for transactivation was located between
bp 2490 and 2470 (Fig. 6B). Deletion of this sequence within
the bp 2750 to 2350 fragment decreased transactivation by
more than 80%. When ligated to the minimal TGase I promoter
(D10; Fig. 6B) this fragment increased the level of reporter
gene activity by more than 10-fold. The 2490 to 2470 sequence
consists of the almost perfect palindromic structure CTGGCT-
GCTGATGTCACCAGCCAG (referred to as TGpal) containing
a CREB/AP-1-like sequence (TGATGTCA) in the middle (Fig.
6C). It is interesting to note that this palindromic region in-
cluding the CREB/AP-1-like element is highly conserved in the
corresponding 59-flanking region of the human TGase I gene
(Fig. 6C).
Fig. 7 shows that the CREB/AP-1-like element (TGpal) and
the Sp1 site are acting in concert to optimally increase tran-
scription. Each element used separately with the minimal pro-
moter increased transactivation of the reporter, while together
(TGpal/254) they synergistically enhanced transactivation to a
level slightly less than that of the full 2.9-kb 59-flanking region.
To directly map protein binding sites in the 2750/2350
region of the TGase I promoter, nuclear extracts from squa-
mous differentiated RbTE cells and a 400-bp DNA fragment
(2750/2350) were used for DNase I footprint analysis. Al-
though several DNA elements were found to be protected, the
region between bp 2490 and 2470 containing the TGpal was
one of the most strongly protected sequences (Fig. 8).
TGase I Promoter Contains a Functional CREB/AP-1-like
Element—To determine which bases in the TGpal element are
optimal for its transactivation function, mutated oligonucleo-
tides M1–M8 (Fig. 9A) were inserted upstream of the 237/160
basic promoter region of pTG(237)-LUC. The transcriptional
activity of these constructs was tested in differentiating RbTE
cells by transient transfection assays. As demonstrated in Fig.
9B, transactivation of the LUC reporter under the control of
TGpal was increased about 10-fold compared with the activity of
the basic promoter. The mutations (M2–M7) that disrupt tran-
scriptional activation most are within the CREB/AP-1-like se-
quence (TGATGTCA).
To map the exact position of the enhancer element within the
2490/2470 region of the TGase I promoter, we performed
EMSA with a 32P-labeled TGpal oligonucleotide and nuclear
extracts isolated from differentiated RbTE. Several oligonu-
cleotides (M1–M8; Fig. 9A), containing different point muta-
tions in this region, were tested for their ability to compete with
32P-labeled TGpal for protein binding. The oligonucleotide M1
competed as effectively as the unlabeled TGpal itself (Fig. 10A).
The oligonucleotides M2–M4 and M8 were less effective com-
petitors than unlabeled TGpal, while M6, M7, and to a lesser
degree M5 did not compete well for binding. These results
indicate that TCA within the CREB-like element is optimal for
the formation of DNA-protein complexes. Since TGpal contains
an element that shows similarity to CREB and AP-1 sites, we
FIG. 4. Comparison of TGase I promoter activity in NHEK,
RbTE, and rabbit tracheobronchial fibroblasts (RbF). Cells were
transfected with b-actin-CAT and either pTG(254)-LUC, pTG(237)-
LUC, pTG(2750)-LUC, pTG(750*)-LUC, or pTG(22.9)-LUC reporter
plasmid DNA as described under “Experimental Procedures” and 48 h
later assayed for luciferase activity and CAT protein levels. The relative
luciferase activity for each construct was calculated and plotted.
pTG(750*)-LUC is identical to pTG(750)-LUC except that it does not
contain the region between bp 237 and 2350.
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assessed the ability of consensus AP-1 (TGAGTCA) and CREB
(TGACGTCA) oligonucleotides to compete with 32P-labeled
TGpal for binding to nuclear proteins from squamous differen-
tiated RbTE cells. As shown in Fig. 10B, both the consensus
AP-1 and CREB oligonucleotides were able to compete with
TGpal; however, they were less efficient than TGpal itself.
To determine the identity of some of the proteins in the
complexes binding to TGpal, supershift analysis was carried out
with nuclear extracts from squamous differentiated RbTE cells
and antibodies against various members of the Jun, Fos,
CREB, and ATF families of transcription factors. These anal-
yses identified CREB1, c-Jun Fra-1, and c-Fos as part of pro-
tein complexes bound to TGpal (Fig. 11A). These proteins were
also found in complexes bound to a consensus CREB oligonu-
cleotide and, except for CREB1, also in complexes bound to a
consensus AP-1 oligonucleotide (Fig. 11, B and C). The anti-c-
Fos antibody caused a supershift of almost all of the protein-
AP-1 complexes, while this shift is much less dramatic with
TGpal or CREB oligonucleotides. The supershift with anti-Fra-1
antibody was most pronounced with AP-1 oligonucleotide and
very weak with TGpal. These differences in the degree of the
supershift are likely to be an indication of the differences in the
affinity of the transcriptional factor for the particular DNA
element and the amount of the protein present in the bound
complexes. Antibodies specific for Ser63-phosphorylated (ac-
tive) c-Jun or JunB were also able to cause a supershift of
TGpal-protein complexes (not shown), whereas antibodies
against JunD, ATF2, ATF4, Fra-2, and CREB2 did not cause
supershifts (not shown).
DISCUSSION
In this study, we analyzed the promoter activity of the 2.9-kb
59-flanking region of the rabbit TGase I promoter in vivo and in
vitro. Analysis of the TG(22.9)-CAT transgenic mice revealed
that CAT mRNA was only expressed in squamous tissues and
was restricted to the suprabasal layers comprising the late
spinous and granular cell layers. This pattern of transgene
expression correlates well with that reported for endogenous
TGase I mRNA (47). These results demonstrate that this 2.9-kb
region contains elements that are sufficient to direct the tissue-
FIG. 5. The proximal TGase I promoter contains a functional Sp1 element. A, sequence of the oligonucleotide TG-Sp1 encoding the region
from 254 to 235 bp. The location of the two mutations in the oligonucleotide TG-mtSp1 or reporter construct pTG-(2mt54)-LUC are indicated. The
sequence of the commercial Sp1 oligonucleotide (Sp1cons.) is also shown. B, RbTE cells were transfected with pTG(237)-LUC (237), pTG(254)-
LUC (254) or pTG(2mt54)-LUC (254mt) and 48 h later collected and assayed for luciferase activity as described under “Experimental Procedures.”
The data shown are the mean of triplicate dishes. C, EMSA was carried out with 32P-labeled TG-Sp1 and nuclear extracts from squamous-
differentiated RbTE cells in the presence or absence of a 100-fold excess of unlabeled TG-Sp1, TG-mtSp1, or the commercial Sp1 oligonucleotide.
D, supershift (arrow) of protein complexes was carried out by including specific antibodies against Sp1, -2, or -3 in the incubation mixture.
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and differentiation-specific expression of TGase I in vivo and
are in agreement with a recent report on the promoter activity
of the human TGase I in transgenic mice (54). This conclusion
is supported by observations in cultured cells showing that the
2.9-kb region of the TGase I promoter is able to control the
transcription of a reporter gene in a cell type- and differentia-
tion-specific manner (Fig. 4; Refs. 34 and 52).
In order to locate the regulatory elements required to drive
TGase I expression during squamous differentiation, a series of
deletions were made to the 2.9-kb 59-flanking sequence. This
analysis mapped the minimal promoter to 237/160 and iden-
tified two major sites that are important in the transcriptional
control of TGase I: a palindromic sequence from 2490 to 2470
bp (TGpal) containing a CREB/AP-1-like site in the middle and
the region from bp 253 to 237 consisting of a functional Sp1
site. We showed that these two elements work in concert to
regulate the basal promoter activity of the TGase I gene. Pre-
vious studies implicated several AP-2-like sites in the tran-
scriptional regulation of human TGase I in NHEK cells (51);
these sites may cooperate with the Sp1 and TGpal elements.
The GC-rich region containing the Sp1 consensus element is
located just upstream from the TATA-like box. Point mutations
in this element reduce promoter activity to that of the minimal
TGase I promoter (Fig. 5). Although another consensus Sp1
sequence is present at bp 2194, no evidence was obtained
indicating that this site is important in the regulation of the
TGase I gene. Sp1 elements have been reported to be able to
bind a number of transcriptional factors including members of
the Sp1 family (56). Sp1 contains a DNA-binding domain con-
sisting of three zinc fingers and binds the consensus sequence
59-GGGCGG. In addition to Sp1, three related genes (Sp2, -3,
and -4) have been identified (56, 57). These transcription fac-
tors can act alone or in cooperation with other transcription
factors and can enhance or repress transcription depending on
promoter context and cell type. Sp1 elements have been linked
to the regulation of several genes during squamous differenti-
ation. The Sp1 site is needed for optimal transcriptional acti-
vation of the involucrin gene, and protein complexes bound to
this site were found to contain Sp1 but not Sp2, -3, or -4 (57).
Sp1 sites have also been implicated in the regulation of
SPRR-2A (59) and TGase III (60). Our mobility shift analysis
demonstrated that in differentiated RbTE cells, Sp1 and to a
FIG. 6. Functional analysis of vari-
ous deletions of the 2750/2350 5*-
flanking region of the TGase I gene.
A, schematic view of the various deletions
D1–D11 made in the 2750 to 2350 up-
stream flanking region. B, analysis of the
ability of the various 59-flanking regions
to regulate the transcription of the lucif-
erase reporter gene in differentiating
RbTE cells. The relative luciferase activ-
ity for each construct was calculated and
plotted. The -fold induction from the ac-
tivity of the minimal promoter is shown
on the right in A. C, comparison of the
nucleotide sequence of the corresponding
59-flanking regulatory region containing
the TGpal (underlined) and CREB/AP-1-
like site (boldface type) in the rabbit and
human TGase I gene. The arrows indicate
palindromes.
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minor extent Sp3 are part of protein complexes that interact
with the TG-Sp1 element. A recent study has demonstrated
that the ratio of Sp1 to Sp3 is low in undifferentiated and high
in squamous-differentiated NHEK cells and that Sp1 is in-
volved in the differentiation-specific regulation of HPV-16
genes (61). This differential expression may hint at a possible
role for Sp1-Sp3 antagonism during squamous differentiation.
Antagonism of Sp1-mediated transcriptional activation by Sp3
has been demonstrated in several other cell systems (56). In
contrast to these observations, the differentiation-dependent,
transient induction of the cyclin-dependent kinase inhibitor
p21WAF1/Cip1 during early stages of squamous differentiation in
NHEK cells has been reported to depend on the interaction of
Sp3 rather than Sp1 with a GC-box in the proximal promoter
region of p21WAF1/Cip1 (62). The reported increase in the Sp1/
Sp3 ratio during differentiation may be a later event and be
part of the down-regulation of p21WAF1/Cip1. Moreover, the ac-
tivation or repressor function of Sp3 may be determined by the
sequence or context of the GC-box.
The functionally important CREB/AP-1-like element TGAT-
GTCA is contained in a 22-bp palindrome that is protected in
DNase I footprinting assays. Point mutations in the CREB/AP-
1-like site reduced promoter activity of this site, supporting the
importance of the CREB/AP-1 motif. The CREB/AP-1-like ele-
ment has been shown to bind a variety of transcriptional fac-
tors, including members of the CREB, ATF, and Fos/Jun fam-
ilies (63). Mobility shift assays using an array of antibodies
against different CREB/AP-1-binding proteins demonstrated
that TGpal interacted with protein complexes containing
CREB1, c-Jun, JunB, Fra-1, and c-Fos in nuclear extracts from
differentiated RbTE cells. CREB/AP-1-like elements have been
implicated in the transcriptional regulation of several other
squamous marker genes, including involucrin, profilaggrin,
and SPRR-1 genes (64–67). It is likely that the regulation of
squamous-specific genes, which are induced at different stages
during differentiation, involves control by different CREB/AP-1
protein complexes. The differential expression of members of
the Jun/Fos family during different stages of squamous differ-
entiation is in agreement with this concept (68). A role for
CREB/AP-1-like elements is further supported by studies
showing that PKC activation, which regulates the expression of
Jun/Fos family members, is an important component of the
signaling pathways controlling squamous differentiation and
FIG. 7. The Sp1 and CREB-like site act in concert to enhance
transcription of the TGase I gene. Reporter plasmids containing the
LUC reporter gene under the control of the minimum TGase I promoter
(237), the 254 to 160 promoter region including the Sp1 site (254), the
minimal promoter plus TGpal (TGpal/237), the 254 to 160 promoter
region plus TGpal (TGpal/254), or the 22.9 kb regulatory region (22.9K)
were transfected into differentiated RbTE cells. After 48 h, cells were
assayed for reporter gene activities, and the relative LUC activity was
calculated.
FIG. 8. DNase I footprint analysis of the 2350/2450 promoter
flanking region of the TGase I gene. Footprint analysis was carried
out as described under “Experimental Procedures.” Lane 1, no nuclear
extract; lane 2, nuclear extract from squamous differentiated RbTE
cells. The protected region coincides with that of TGpal as indicated by
the sequence on the right.
FIG. 9. Effect of various mutations on the ability of TGpal to
increase transcription of the luciferase reporter. A, sequence of
TGpal (wt) and mutated oligonucleotides M1–M8. B, the different oligo-
nucleotides were inserted into pTG(237)-LUC just upstream from the
minimal promoter, and their ability to regulate the transcription of the
luciferase reporter gene was analyzed.
Transcriptional Regulation of Transglutaminase I3894
 at UQ Library on October 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
TGase I (34, 68–71). Cholesterol sulfate, which is highly in-
duced during squamous differentiation (71), can function as an
endogenous second messenger and through the activation of
different PKC isoforms enhance the expression of several squa-
mous-specific genes, including TGase I (52, 70).
The role of specific CREB/AP-1 complexes in squamous dif-
ferentiation is not yet well understood. Recent studies have
demonstrated that expression of c-Fos appears not to be essen-
tial for squamous differentiation in the epidermis, since epi-
dermal differentiation is normal in c-Fos null mice (68). Others
have suggested that JunB may be involved in the induction of
early markers, including involucrin and TGase I, while JunD
may play a role in the control of later markers, such as pro-
filaggrin (65). A role for JunB in TGase I regulation is sup-
ported by immunohistochemical studies showing that JunB is
predominantly present in the granular layer where TGase I is
also expressed (47, 68) and by EMSA demonstrating the pres-
ence of JunB in protein complexes binding TGpal. It is clear that
multiple protein complexes in squamous differentiated cells
can compete for binding to TGpal. Some of these complexes may
act as repressors, while others may function as stimulators of
gene transcription. Therefore, increased transcription of squa-
mous-specific genes may depend on the level and activity of
these complexes during the differentiation process. This may
involve changes in heterodimerization partners that could alter
the affinity and activity of the complex. This concept is sup-
ported by recent findings showing that ectopic expression of a
dominant-active c-Jun has a repressive effect on the expression
of several squamous-specific genes, including involucrin and
SPRR-1 (73). In addition, it was demonstrated that c-Jun is
expressed predominantly in basal and early spinous layer and
that the level of c-Jun and phosphorylated c-Jun is dramati-
cally down-regulated during squamous differentiation and is
probably related to the observed reduction in JNK activity
(68).3 These findings support a negative regulatory role of
c-Jun in the control of squamous differentiation. The latter is in
agreement with observations showing that squamous cell
markers are not induced in squamous cell carcinoma cell lines
overexpressing c-Jun (73).
In this study, we show that the 2.9-kb 59-flanking region of
the TGase I gene can regulate this gene in a tissue- and differ-
entiation-specific manner and identify two DNA elements im-
portant in its transcriptional control. It is known that certain
forms of lamellar ichthyosis are linked to defects in the expres-
sion of the TGase I gene (11, 12). In some cases, this genetically
heterogeneous disease might be caused by mutations in tran-
scriptionally important promoter regions of TGase I. Therefore,
the study of this promoter region could help in understanding
the nature of this disease and provide a tool for gene therapy of
lamellar ichthyosis and other skin disorders.
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